Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Alessi

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese womenS Ei Ayachi, O Paulmyer-Lacroix, M Verdier, et al.
Thrombosis and Haemostasis|August 24, 1999
Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary arteryF Paganelli, M C Alessi, P Morange, et al.
Thrombosis Research|October 15, 1990
Lupus anticoagulants and antiphospholipid antibodies: comparison of clotting tests with an immunological assayM F Aillaud, D Reviron, M C Alessi, et al.
Circulation|August 5, 1997
Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levelsW L Chandler, M C Alessi, M F Aillaud, et al.
Journal of Lipid Research|January 1, 1993
Phosphatidylinositol turnover during stimulation of plasminogen activator inhibitor-1 secretion induced by oxidized low density lipoproteins in human endothelial cellsM Chautan, Y Latron, F Anfosso, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cellsY Latron, M Chautan, F Anfosso, et al.
Blood|January 1, 1988
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assayP J Declerck, M C Alessi, M Verstreken, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand diseaseY C Piao, J M Lavergne, C Boyer-Neumann, et al.
Blood|January 1, 1996
Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937F Peiretti, C Fossat, F Anfosso, et al.
Circulation|November 1, 1996
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and DisabilitiesI Juhan-Vague, S D Pyke, M C Alessi, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Journal of Thrombosis and Haemostasis : JTH|February 8, 2006
11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese womenS Ei Ayachi, O Paulmyer-Lacroix, M Verdier, et al.
Thrombosis and Haemostasis|August 24, 1999
Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary arteryF Paganelli, M C Alessi, P Morange, et al.
Thrombosis Research|October 15, 1990
Lupus anticoagulants and antiphospholipid antibodies: comparison of clotting tests with an immunological assayM F Aillaud, D Reviron, M C Alessi, et al.
Circulation|August 5, 1997
Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levelsW L Chandler, M C Alessi, M F Aillaud, et al.
Journal of Lipid Research|January 1, 1993
Phosphatidylinositol turnover during stimulation of plasminogen activator inhibitor-1 secretion induced by oxidized low density lipoproteins in human endothelial cellsM Chautan, Y Latron, F Anfosso, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1991
Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cellsY Latron, M Chautan, F Anfosso, et al.
Blood|January 1, 1988
Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assayP J Declerck, M C Alessi, M Verstreken, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 1993
Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand diseaseY C Piao, J M Lavergne, C Boyer-Neumann, et al.
Blood|January 1, 1996
Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937F Peiretti, C Fossat, F Anfosso, et al.
Circulation|November 1, 1996
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and DisabilitiesI Juhan-Vague, S D Pyke, M C Alessi, et al.
Pageof 15